Latest news
Welcome to the Syngene newsroom. Click the titles of our latest news releases to read the full item, or click on the ‘More news releases’ link to go to the News archive.
Syngene’s 2D image analysis systems being used in critical research to analyse the efficacy of novel treatments for brain tumours
Dyversity 2 image analyser and Dymension 2D analysis software are being used at US biopharmaceutical company, the Burzynski Research Institute (BRI), to determine the molecular effects compounds have on brain tumours.
Versatile Dyversity system at leading European Cancer Research Centre rapidly analyses fluorescent and chemiluminescent proteins with ease
Syngene’s Dyversity multi-application image analyser is being used by scientists in The Cancer Research UK Cambridge Research Institute (CRI) at the University of Cambridge, one of Europe’s major cancer research hubs, to accelerate the pace of research on proteins and DNA associated with a variety of different cancers.
University of Lausanne uses Dyversity for analysing triple labeled DIGE gels to help rapidly identify proteins associated with neurodegenerative diseases
Syngene’s Dyversity 2D imaging system is being used by one of Europe’s leading research institutes, the University of Lausanne in Switzerland, to help identify proteins associated with neurodegenerative diseases.
 More news releases
|
